The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.018
Bid: 0.017
Ask: 0.019
Change: 0.00 (0.00%)
Spread: 0.002 (11.765%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.018
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new independent Non-Executive Chair

6 Jun 2022 07:00

RNS Number : 7706N
Supply @ME Capital PLC
06 June 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

6 June 2022

 

Supply@ME Capital plc

(The "Company" or "SYME")

Appointment of new Chair:

Supply@ME appoints Albert Ganyushin as new independent non-executive chairman

 

Supply@ME Capital plc, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, is pleased to announce that the Board of Directors proposes to appoint Albert Ganyushin as a director and new independent non-executive chairman with effect from the conclusion of its Annual General Meeting envisaged by the end of June 2022. He will succeed James Coyle, who stepped down from the role in March of this year.

Mr Ganyushin was appointed as an independent adviser (the "Adviser") to the Company, as stated in the RNS of 4 March 2022 when SYME announced the appointment of the Adviser to complete, inter alia, its strategic review. He has subsequently conducted an assessment of the business focussing on the long-term business objectives and its governance requirements. Mr Ganyushin's knowledge, skills and experience identify him as an excellent candidate to lead the business through its next stage of growth. He will provide leadership, support, and strategic guidance during a period of significant change for the business.

His two-decade career comprises a range of increasingly senior investment and capital markets roles across the US, UK, continental Europe and emerging markets. Mr Ganyushin has a wealth of public markets experience including as Head of International Listings at the New York Stock Exchange and Euronext and Investment Banking at Deutsche Bank. Most recently, Mr Ganyushin has worked as Head of Capital Markets at Dr. Peters Group, an alternative investment and asset manager with a track record of investing and managing over US$8bn in real assets across the transportation infrastructure (shipping and aviation) and specialist real estate. Mr Ganyushin holds an MBA from the London Business School.

SYME Chief Executive, Alessandro Zamboni said:

"I am very pleased to welcome Albert to Supply@ME. He will bring a wealth of capital markets and investment experience and will be a valuable asset when it comes to guiding the Company through its next stage. I look forward to working with him."

SYME Chair, Albert Ganyushin said:

"I am delighted to be joining Supply@ME as its new chair. The opportunity that lies ahead of Supply@ME is clear. I'm looking forward to bringing my experience to help shape the next stage of the development of Supply@ME's unique offering."

 

The following information is disclosed in respect of Mr Ganvushin pursuant to the Financial Conduct Authority's Listing Rules:

 

 

Albert Ganyushin holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Austen Grove Capital Limited

Westcott Hill Capital Limited

Wotton Hill Capital LLP

 

Past Directorships or Partnerships

Dr. Peters Asset Invest Ltd

Ross Wisconsin AS

 

Mr Ganyushin does not hold any interests in any shares in the Company.

 

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317; brian.norris@cicero-group.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUGGQUPPUAQ
Date   Source Headline
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202212:22 pmRNSPublication of Prospectus & Total Voting Rights
30th Sep 20224:18 pmRNSTotal Voting Rights
29th Sep 20227:00 amRNS2022 Interim Results
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.